Results 211 to 220 of about 429,144 (355)

Pharmacology, Materia Medica, and Therapeutics [PDF]

open access: yesThe American Journal of Nursing, 1935
Hazel Houston   +2 more
openaire   +2 more sources

Semiconducting Polymer Nanoparticles as Multimodal Agents for Optical and Magnetic Resonance Imaging

open access: yesAdvanced Healthcare Materials, EarlyView.
Semiconducting polymer nanoparticles (SPNs) exhibit many advantageous optical and biological properties. Multimodal SPN‐based contrast agents that integrate several imaging modalities yield a wealth of information through the use of different imaging mechanisms.
Faysal A. Farah   +3 more
wiley   +1 more source

Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Response to Letter]

open access: yesDrug, Healthcare and Patient Safety
Fawzi Thomas,1,2 Onome T Abiri,2,3 Joyce M Kallon,4 Desmond Maada Kangbai,4 Thomas A Conteh,1,2 Sally-Mattu Conteh,4 Edna G Samuels,4 Olufunsho Awodele5 1Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, College of Medicine and Allied ...
Thomas F   +7 more
doaj  

Physiological Significance of Endothelial M3 Muscarinic Receptors During Exercise. [PDF]

open access: yesCirc Res
Ackland GL   +12 more
europepmc   +1 more source

Aging on Chip: Harnessing the Potential of Microfluidic Technologies in Aging and Rejuvenation Research

open access: yesAdvanced Healthcare Materials, EarlyView.
This review highlights recent advances in microfluidic technologies for modeling human aging and age‐related diseases. It explores how organ‐on‐chip platforms improve physiological relevance, enable rejuvenation strategies, facilitate drug screening, detect senescent cells, and identify biomarkers.
Limor Zwi‐Dantsis   +5 more
wiley   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

open access: yesAdvanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han   +7 more
wiley   +1 more source

Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1123. [PDF]

open access: yesPharmaceuticals (Basel)
Mohammed OA   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy